# The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals

> **NCT07687589** · NA · ENROLLING_BY_INVITATION · sponsor: **University of Copenhagen** · enrollment: 14 (estimated)

## Conditions studied

- Emesis

## Interventions

- **OTHER:** Glucose-dependent Insulinotropic Polypeptide (GIP)
- **OTHER:** GLP-1 (7-36) amide
- **OTHER:** Apomorphine Injectable Solution
- **OTHER:** Saline (0.9% NaCl)

## Key facts

- **NCT ID:** NCT07687589
- **Lead sponsor:** University of Copenhagen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2026-05-19
- **Primary completion:** 2026-11-30
- **Final completion:** 2027-04-28
- **Target enrollment:** 14 (ESTIMATED)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687589

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687589, "The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07687589. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*